SCHEMBL20222744

SCHEMBL20222744

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc5c(c4)-c4ccc6ccccc6c4Sc4ccccc4-c4ccccc4-c4ccccc4-5)cc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ MAPT P10636 5/20 0.40
▸ SMN1; SMN2 Q16637 4/20 0.40
▸ ATM Q13315 3/20 0.40
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ L3MBTL1 Q9Y468 3/20 0.40
▸ LMNA P02545 2/20 0.40
▸ APAF1 O14727 1/20 0.40
▸ THRB P10828 1/20 0.40
▸ XBP1 P17861 1/20 0.40
▸ PTBP1 P26599 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ GALK1 P51570 1/20 0.40
▸ BLM P54132 1/20 0.40
▸ SMAD3 P84022 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ ALDH1A1 P00352 4/20 0.35
▸ HSD17B10 Q99714 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20222636 0.97 MEN1 (0.37) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL20222637 0.96 MAPT (0.38) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL20222626 0.96 MAPT (0.36) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL20222635 0.95 MAPT (0.38) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL20222638 0.94 MAPT (0.35) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL20222687 0.90 HPGD (0.40) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL20222743 0.89 SMN1; SMN2 (0.40) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL20222686 0.89 CYP11B1 (0.40) MEN1KMT2AMAPTSMN1; SMN2NPC1
SCHEMBL20222684 0.89 MEN1 (0.38) MEN1KMT2AMAPTSMN1; SMN2ATM
SCHEMBL20845242 0.86 SMN1; SMN2 (0.34) MEN1KMT2AMAPTSMN1; SMN2ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10693077-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2020-06-23 — — US disclosed
US-20180155312-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10693077-B2 Compound and organic electronic device using the same SOD1, SCO2, RCOR3 MEN1 2385/4885KMT2A 1209/4885MAPT 3350/4885
US-20180155312-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME SOD1, SCO2, RCOR3 MEN1 2385/4885KMT2A 1209/4885MAPT 3350/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback